Skip to content
Thursday, February 9, 2023
Latest:
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
  • Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
  • Amgen announces Artificial Intelligence (AI) Partnership with Mila
Biotech Stock Market Report

Biotech Stock Market Report

Know First, Act First

  • Covid-19
  • General
  • Financing
  • Pharma
  • Global
  • Trending

Financing

BIOTCHNO Financing 

AmpliTech Announces Closing of Upsized $9.6 Million Public Offering

February 19, 2021April 8, 2021 Bachittar

Bohemia, New York–(Newsfile Corp. – February 19, 2021) – AmpliTech Group, Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) (the “Company”), a designer,

Read more
BIOTCHNO Financing 

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020

February 18, 2021April 16, 2021 Bachittar

  Canada NewsWire KELOWNA, BC,Feb. 18, 2021/CNW/ –The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the“Company,” “The Valens Company” or“Valens”), a leading

Read more
BIOTCHNO Financing 

Seegene posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-won club

February 18, 2021April 16, 2021 Bachittar

  Canada NewsWire SEOUL, South Korea,Feb. 18, 2021/CNW/ —South Korea’sleading molecular diagnostics firm Seegene Inc. (KQ096530) reported preliminary financial results

Read more
BIOTCHNO Financing 

ESSA Pharma Announces Pricing of Public Offering of Common Shares

February 17, 2021April 16, 2021 Bachittar

  Canada NewsWire VANCOUVER, BCandHOUSTON,Feb. 17, 2021/CNW/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (Nasdaq: EPIX), a clinical-stage pharmaceutical

Read more

Covid-19

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
BIOTCHNO Covid-19 

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate

December 14, 2020April 16, 2021 vanessa

VICTORIA, BC,Dec. 14, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (“IPA”) (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation
BIOTCHNO Covid-19 

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

November 30, 2020April 16, 2021 vanessa
Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.
BIOTCHNO Covid-19 

Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.

November 26, 2020April 16, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057